Rhythm Pharmaceuticals’ (RYTM) Buy Rating Reaffirmed at HC Wainwright
Rhythm Pharmaceuticals (NASDAQ:RYTM – Get Free Report)‘s stock had its “buy” rating reaffirmed by HC Wainwright in a report issued on Monday,Benzinga reports. They presently have a $70.00 target price on the stock. HC Wainwright’s target price suggests a potential upside of 32.30% from the stock’s previous close. HC Wainwright also issued estimates for Rhythm […]
Rhythm Pharmaceuticals (NASDAQ:RYTM – Get Free Report)‘s stock had its “buy” rating reaffirmed by HC Wainwright in a report issued on Monday,Benzinga reports. They presently have a $70.00 target price on the stock. HC Wainwright’s target price suggests a potential upside of 32.30% from the stock’s previous close. HC Wainwright also issued estimates for Rhythm […]
